Transforming Growth Factor β Receptor I Kinase Inhibitor Down-Regulates Cytokine Secretion and Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment

Keywords

Humanities, Philosophy

References

• Transforming growth factor-β signaling in normal and malignant hematopoiesisAiste Dackauskaite — 2003
• Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.Jason S. Damiano, Anne E. Cress, Lori Hazlehurst — 1999
• TGF-β signaling in tumor suppression and cancer progressionRik Derynck, Rosemary J. Akhurst, Allan Balmain — 2001
• IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.Atsushi Ogata, Dharminder Chauhan, Gerrard Teoh — 1997
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisPeter Carmeliet, Yuval Dor, Jean-Marc Herbert — 1998
• Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.Berno Dankbar, Teresa Padró, Regine Leo — 2000
• Transforming growth factor-β in T-cell biologyLeonid Gorelik, Richard A. Flavell — 2002
• Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis.Nicolas O. Fortunel, Antoinette Hatzfeld, Jacques Hatzfeld — 2000
• Adhesion-Mediated Intracellular Redistribution of c-Fas-Associated Death Domain-Like IL-1-Converting Enzyme-Like Inhibitory Protein-Long Confers Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines1Kenneth H. Shain, Terry H. Landowski, William S. Dalton — 2002
• Molecular mechanisms of novel therapeutic approaches for multiple myelomaTeru Hideshima, Kenneth C. Anderson — 2002
• Thalidomide is an inhibitor of angiogenesis.Robert J. D’Amato, Michael Loughnan, Evelyn Flynn — 1994
• Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3Isabelle Vande Broek, Kewal Asosingh, Karin Vanderkerken — 2003
• Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathwaysJae‐Il Park, Min Goo Lee, Kyucheol Cho — 2003
• Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.Toshiaki Hayashi, Teru Hideshima, Masaharu Akiyama — 2003
• Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myelomaTeru Hideshima, Noriaki Nakamura, Dharminder Chauhan — 2001
• Apaf-1/Cytochrome c-independent and Smac-dependent Induction of Apoptosis in Multiple Myeloma (MM) Cells*Dharminder Chauhan, Teru Hideshima, Steven T. Rosen — 2001
• Smad-dependent and Smad-independent pathways in TGF-β family signallingRik Derynck, Ying E. Zhang — 2003
• Recombinant humanized anti‐CD40 monoclonal antibody triggers autologous antibody‐dependent cell‐mediated cytotoxicity against multiple myeloma cellsToshiaki Hayashi, Steven P. Treon, Teru Hideshima — 2003
• Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD. Gupta, SP Treon, Yoshihito Shima — 2001
• Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF ExpressionShu-Ching Shih, Kevin P. Claffey — 2001

Cited by

• Hepatocellular stem cellsKrit Kitisin, Kirti Shetty, Lopa Mishra — 2007
• Rôle du système IGF-1/insuline dans le Myélome MultipleAnne Catherine Sprynski — 2009
• CDK2 Phosphorylation of Smad2 Disrupts TGF-β Transcriptional Regulation in Resistant Primary Bone Marrow Myeloma Cells1Linda B. Baughn, Maurizio Di Liberto, Rubén Niesvizky — 2009
• Role of transforming growth factor-beta in hematologic malignancies.Mei Dong, Gerard C. Blobe — 2006
• Identification and validation of novel therapeutic targets for multiple myeloma.Teru Hideshima, Dharminder Chauhan, Paul G. Richardson — 2005
• Targeting Transforming Growth Factor-β (TGF-β) in Cancer and Non-Neoplastic DiseasesMichael Nacif, Olfat Shaker — 2014
• Tissue expression of TGF-β1 in uterine cervical samples from HIV/AIDS patients.Thiago Xavier Carneiro, Juliana Torres Pacheco, Marília Brasil Xavier — 2012
• Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone MicroenvironmentLauren K. Dunn, Khalid S. Mohammad, Pierrick G.J. Fournier — 2009
• The polarization of immune cells in the tumour environment by TGFβRichard A. Flavell, Shomyseh Sanjabi, Stephen H. Wrzesinski — 2010
• Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studiesMaria Antonia Frassanito, Luigia Rao, Michele Moschetta — 2014
• Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.Carole Y. Perrot, Delphine Javelaud, Alain Mauviel — 2013
• Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stromaFeng Yang, Douglas W. Strand, David R. Rowley — 2008
• Towards a new age in the treatment of multiple myelomaFrancesco Piazza, Carmela Gurrieri, Livio Trentin — 2007
• Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions.Kenneth C. Anderson — 2007
• New Frontiers in the Treatment of Multiple MyelomaJanice J. Hwang, Irene M. Ghobrial, Kenneth C. Anderson — 2006
• Novel anti-myeloma agents and angiogenesisKonstantinos Anargyrou, Meletios Α. Dimopoulos, Orhan Sezer — 2008
• Dysregulation of growth factor signaling in human hepatocellular carcinomaKai Breuhahn, Thomas Longerich, Peter Schirmacher — 2006
• The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myelomaEvangelos Terpos, M-A Dimopoulos, Orhan Sezer — 2007
• Cell Trafficking in Multiple MyelomaGiada Bianchi, Shaji Kumar, Irene M. Ghobrial — 2012
• Novel therapeutic strategies targeting growth factor signalling cascades in multiple myelomaHiroshi Yasui, Teru Hideshima, Paul G. Richardson — 2005

Related papers

No related papers recorded.